N/A
- Biotechnology
- CNS Gene Therapy Market
CNS Gene Therapy Market
CNS Gene Therapy Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 - 2028
Market Overview:
Gene therapy is a technique in which genetic material is used to prevent or cure diseases such as genetically inherited disorders, neurodegenerative diseases, viral infections, and even cancer. CNS gene therapy can offer permanent treatment for life-threatening diseases such as Parkinson’s disease, Alzheimer's disease, Huntington's disease, Batten disease and many more. In CNS gene therapy DNA is introduced in the host body through a vector that is designed to modify the expression of an abnormal gene and treat the disease.
According to WHO, the burden of CNS is increasing each year and is expected to reach 103 million disability-adjusted life years (DALYs) in 2030. CNS gene therapy aims to augment the gene expression or inhibit it. Desirable gene expression is thus achieved by undergoing CNS gene therapy, however, only a select number of genes are modifiable to cure diseases till date.
The exponentially increasing demand for treatment of incurable CNS disease is luring manufacturers to invest in CNS gene therapy market. Many leading players in biotechnology and pharmaceutical sectors such as Pfizer, Sanofi, Novartis, Abbott Laboratories, etc. are entering the CNS gene therapy market and the global gene therapy finances increased by 35% in 2018 as compared to 2017.
The growing number of clinical trials and research papers supporting the pieces of evidence of successful CNS gene therapy is expected to drive the CNS gene therapy market over the forecast period.
CNS gene therapy is considered to be very expensive, as it therefore often requires an individual, case-by-case approach. This factor may hamper mass adoption of CNS gene therapy in the market over the forecast period. Although the future of CNS gene therapy beholds huge potential for growth, it is limited to developed countries with high healthcare and research and development expenditure over the forecast period.
Stringent regulations and complications related to interference of foreign genetic material are expected to be a restraint in the expansion of CNS gene therapy market.
The report covers exhaustive analysis:
- CNS gene therapy Market Segments
- CNS gene therapy Market Dynamics
- Historical Actual Market Size, 2013 - 2017
- CNS gene therapy Market Size & Forecast 2018 to 2026
- CNS gene therapy Market Current Trends/Issues/Challenges
- Competition & Companies involved
- CNS gene therapy Market Drivers and Restraints
Report Highlights:
- Shifting industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size recent industry trends
- Key competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
